Tablet Process Development and Validation and the application of QbD

Course objectives
This interactive workshop provides up-to-date, relevant and detailed information on the impact of Quality by Design (QbD) on the Development and Validation of tablet manufacturing processes. It will also study the identification and evaluation of Critical Product Attributes and Critical Process Parameters for tablets, and their
implications for process control. We develop new concepts including the use of risk and process matrices for risk management. The latest ICH and FDA guidance on Quality by Design and Process Development, published in 2009, will be omprehensively reviewed.

By the end of the course, you will
. Understand the relationship between the principles of QbD and tablet development and process validation in generic and new product development
. Understand the relationship between material properties, formulation development and process development
. Understand the processes commonly used to manufacture tablets and the factors which affect them
. Recognise how to identify critical processing parameters, and how to incorporate into a process validation program
. Understand the principles of PAT, how and where it can be most effectively deployed
. Know the latest FDA thinking on Process Development including the three key steps of validation

Day 1:
Morning - Product development
. Principles of Quality by Design and the product development process
. Linking material properties to formulation and processing behaviour
. FDA Guidance on Process Validation
Workshop session - Understanding Quality by Design
Afternoon - Mixing, and dry granulation
. Identifying potential Critical Process Parameters.
. Unit processes 1 - Mixing and blending
. Assessing blend uniformity. Sampling problems and practice
Workshop session - blend assessment practical. Effect of material properties on pow-der mixing behaviour
Day 2:
Morning - EFPIA Case study. Wet granulation
. The new regulatory landscape. Q8, Q9 and Q10 and their impact on product and process development.
. EFPIA case study - what would a QbD regulatory submission look like?
. Use of Process Matrices in process development
. Developing wet granulation processes
. Granulation endpoint control
Afternoon - Drying, compression and film coating
. Drying - techniques and process control
. Compression - opportunities and threats!
. Developing film coating processes
. Round-up session
Day 3: Practical, at County House, Beckenham. Transport provided.
. Blending
. Granulation
. Drying
. Milling
. Sieving
. Compression
. Granule and product characterisation
NOTE
Wherever possible participants should bring practical problems and examples which can be reviewed on the course. The course will be highly participative and useful for people with or without experience. Numbers are restricted to guarantee personal involvement.

Dr Michael Gamlen, Pharmaceutical Development Services - Michael is Managing Director of Pharmaceutical Development Services Ltd, a Nottingham (UK) based technical consultancy. Dr Michael Gamlen has over 30 years experience of tablet development. He has been teaching professional tabletting courses for many years and his courses are highly rated, exceeding the expectation of the participants in many cases.

Dr Dipankar Dey - Dipankar joined PharmaTraining Ltd from Oystar Manesty (Liverpool) where he was Head of Process Development. He has particular expertise in manufacturing of solid dose and bio-pharmaceuticals and has worked in a number of different functions including technology transfer, new product development, training and manufacturing. He also has experience in film coating and the implementation of PAT.

Full fee £1,770 + VAT where applicable.

Discount of 10% applies for booking 8 weeks in advance. Discount of 10% applies for booking more than 1 delegate. Discount of 10% applies for booking more than 1 course. Maximum discount received is 15%